Cation specificity of propranolol-induced changes in RBC membrane permeability: comparative effects in human, dog and cat erythrocytes.
Propranolol, in the presence of calcium, causes marked K efflux from human red blood cells (high K, low Na). The studies reported here indicate this effect of propranolol is specific for K and does not represent a nonspecific permeability increase for intracellular cations to leave the cell. Amphotericin-treated human RBC's (high Na, low K) and dog RBC's (high Na, low K) both gain K and increase in size when incubated in a K-medium containing propranolol and calcium. No effect was noted when cat RBC's (high Na, low K) were similarly treated. Propranolol, independent of added calcium, also inhibited the normally increased Na efflux observed when dog RBC's are suspended in K-medium. These species differences in response to propranolol thus may serve as a focus for elucidating the mechanism by which this drug alters normal membrane physiology. The unique drug effect on Na permeability of canine erythrocytes also may be a useful probe for the study of dog RBC volume regulation.
D000666:Amphotericin B / Q000494:pharmacology; D000818:Animals; D002118:Calcium / Q000494:pharmacology; D002415:Cats; D002463:Cell Membrane Permeability / Q000187:drug effects; D004285:Dogs; D004910:Erythrocyte Membrane / Q000187:drug effects* / Q000378:metabolism; D004912:Erythrocytes / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D011188:Potassium / Q000378:metabolism*; D011433:Propranolol / Q000494:pharmacology*; D012964:Sodium / Q000378:metabolism*; D013045:Species Specificity
D000666:Amphotericin B; D012964:Sodium; D011433:Propranolol; D011188:Potassium; D002118:Calcium